Activist Campaigns Are Reshaping the Buyer Pool

Shareholder activism has shifted from a governance exercise to a transaction engine. Through August, M&A-related demands appeared in 45 of the 83 campaigns launched this year, compared with 21 over the same stretch of 2025. For owners of private companies, this matters less as a headline about public markets and more as a change in who is likely to bid on their business, and how dependable that bidder will be once a process is underway.

What the Campaign Data Shows

Overall activist campaign volume is up roughly 25 percent year over year through August. The composition has changed alongside the count. More than half of campaigns launched this year include an M&A theme, the highest share in five years, and demands specifically pushing a company to sell itself rose close to 50 percent over a recent six-month window. Hedge funds, which tend to run shorter holding periods and press for defined outcomes, accounted for about 68 percent of campaigns this year, up from roughly 59 percent a year earlier.

The demands themselves have widened. Activists are not only calling for outright sales. They are pressing boards to spin off divisions, separate business lines, and divest assets that no longer earn their place in the portfolio. That range of credible outcomes gives an activist more ways to win, and it gives boards more reasons to move before a campaign becomes public.

Deal activity itself has been uneven against that backdrop. Aggregate global monthly deal value in July fell about 39 percent from June to roughly $410 billion, with strategic buyer value dropping around 55 percent month over month. Large transactions continue to dominate the value tally: US megadeals accounted for 64 percent of total US deal value this year, up from 54 percent in 2025, even as overall volumes softened. The picture is a market of fewer, larger strategic transactions layered on top of persistent investor pressure to transact.

Why This Reaches Private Companies

The connection runs through the strategic buyer. Most mid-sized private companies that sell to a corporate acquirer are selling to a public company or to a subsidiary of one. When that acquirer's own shareholders are pressing for portfolio discipline, three things tend to follow.

First, acquisition appetite becomes more selective and more defensible. A public buyer under scrutiny will still pay for assets that clearly advance the stated strategy, sometimes generously, because a well-articulated acquisition is a credible answer to an activist. But that same buyer will not stretch for a business that sits outside the story it is telling investors. Adjacency matters more than it did two years ago.

Second, timelines get less predictable. A company fielding a campaign is allocating board time, management attention, and advisor bandwidth to the campaign. A middle market acquisition that would have moved from indication of interest to signed agreement in ninety days can stall while the board works through a proxy contest or a strategic review. The buyer has not lost interest. It has lost capacity.

Third, and most usefully for private buyers and their advisors, activist pressure generates supply. Divisions that were comfortable inside a large corporate portfolio become available when the parent is being asked to justify every business line. Those carve-outs land in the middle market, where sponsors and strategic consolidators are ready to absorb them.

Pressure Cuts Both Ways in a Sale Process

For a seller, a strategic buyer under investor pressure presents an opportunity and a risk that are difficult to separate.

The opportunity is straightforward. A buyer that needs to demonstrate strategic progress may compete harder and move faster than its financial profile alone would suggest. Deals that clearly extend a core capability or fill a stated gap can attract premium pricing from an acquirer that wants a visible answer for its next earnings call.

The risk is execution. Public company buyers facing campaigns are more likely to renegotiate, extend, or withdraw when their internal circumstances change. That risk shows up in the terms as much as in the outcome: wider financing conditions, longer outside dates, more expansive material adverse effect language, and board approval structures that can be revisited. A seller who reads a high headline number without examining conditionality can end up with an agreement worth considerably less than it appears.

The practical response is not to avoid these buyers. It is to price the risk into how a process is run. That means holding a second bidder in reserve deeper into the process than usual, scrutinizing the buyer's stated timeline against its actual governance calendar, and negotiating certainty terms with the same care applied to price.

What to Watch Through Year End

Three developments deserve attention over the next two quarters. Watch whether the carve-out pipeline continues to build, because if activist pressure keeps pushing large corporates toward portfolio simplification, more divisions will reach the market and competition for the good ones will intensify among sponsors carrying substantial uncommitted capital.

Watch the strategic buyer share of middle market deal value. Strategic value fell sharply in July while sponsor activity held up better. If that gap persists into the fourth quarter, sellers should expect financial buyers to set the pace on price in most processes.

Watch the campaign calendar. Activism is no longer confined to proxy season. Campaigns launched in the fall now routinely carry into the following spring, which means a buyer that looks stable in September may be constrained by January.